Call us now:
The recent Charles River cyber attack, 1st of May, has highlighted the impact of cyber on larger pharmaceutical companies. Whose IP is potentially tied up in their third parties and rely on an integrated supply chain.
Merck reported in their 2018 10-K annual report, that NotPetya cost them, net, $695Mn in lost sales and manufacturing expenses.
View Original Post
https://www.linkedin.com/feed/update/urn%3Ali%3Ashare%3A6532903215019683840